DHR Danaher Corporation Common Stock
NYSE · Life Sciences Tools & Services · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Lip 21, 2026DHR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
DHR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 2 października 2023 | 141-for-125 | Naprzód |
| 5 lipca 2016 | 1319-for-1000 | Naprzód |
| 14 czerwca 2010 | 2-for-1 | Naprzód |
| 21 maja 2004 | 2-for-1 | Naprzód |
| 1 czerwca 1998 | 2-for-1 | Naprzód |
| 23 stycznia 1995 | 2-for-1 | Naprzód |
| 9 września 1987 | 2-for-1 | Naprzód |
O Danaher Corporation Common Stock Przegląd firmy z Wikipedii
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.
History
Early years
The company's origins go back to DMG, Inc., a Massachusetts real estate investment trust organized in 1969. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. In 1983, the Stephen M. Rales and Mitchell P. Rales invested in the company, which at that time was invested in retirement home developments, they then replaced the existing management in a bitter proxy battle.
In 1984, the company adopted the name Danaher and reincorporated under the Delaware General Corporation Law. The name came from a river in Montana.
In 1985, the Rales brothers offered $400 million in a hostile bid for Scott Fetzer Company but lost out to Berkshire Hathaway.
In June 1986, Danaher acquired Chicago Pneumatic in a hostile takeover, offering $60.8 million for the 32% of the company not already owned. The company had merged in July 1984 with a sister company, the Jacobs Manufacturing Co., and had purchased Matco Tools in April 1981.
In June 1987, Danaher sold Chicago Pneumatic while retaining Jacobs, including its Matco Tools Division. Jacobs' name was changed to Matco Tools Corp. In November 1991, the other divisions within Jacobs were established as separate operating companies. In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC.
In 1986, Danaher added Qualitrol to its instrumentation unit, including Gilbarco Veeder-Root's underground fuel storage sensors, Dynapar's motion sensors, and pressure measurement and temperature measurement instruments used on the electrical transformer industry.
1990–2000
In 1990, Danaher acquired Easco Hand Tools Inc. Danaher was selected as exclusive supplier of hand tools for Sears. In 1994, Danaher acquired Armstrong Tools, the makers of tool brands Armstrong, Allen, and others.
In 1995, Danaher acquired Hengstler GmbH, a manufacturer of counters, printers, relays, and high-precision rotational sensors. Hengstler was Danaher's first acquisition headquartered outside the United States.
In 1999, the company acquired Hach Company, involved in water and wastewater—and analytics, for $325 million.
2001–2010
In 2000, H. Lawrence Culp Jr. was named CEO of Danaher; he had joined the company in 1990.
Danaher acquired Trojan Technologies, an environmental engineering firm, in 2004.
Danaher also acquired UK-based West Instruments, which provides control and measurement instrumentation and services for the global industrial and process markets.
Danaher announced its agreement to acquire the Gendex division from DENTSPLY International on
December 11, 2003, with the acquisition closing in early 2004, integrating this dental imaging company into Danaher's growing dental portfolio.
PMA, a German manufacturer of control and measurement instrumentation, was acquired in April 2005.
In July 2005, Danaher acquired Leica Microsystems, which manufactures products for applications requiring microscopic imaging, measurement and analysis and offers management systems for biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.
In early 2007, Danaher acquired Vision Systems, which manufactures and markets automated instruments, antibodies and biochemical reagents for biopsy-based detection of cancer and infectious diseases, for $520 million.
In July 2007, Danaher acquired ChemTreat.
In November 2007, Danaher purchased Tektronix for US$2.85 billion.
In 2009, Danaher acquired the Analytical Technologies business unit of MDS, including a 50% interest in AB SCIEX, for US$650 million. In February 2010, Danaher acquired the remaining 50% ownership position in AB SCIEX from Life Technologies for US$450 million.
2011–2020
In 2011, Danaher acquired Beckman Coulter, which was divided into a diagnostics segment and a life sciences segment.
In January 2012, Danaher sold Accu-sort to Datalogic.
In December 2012, Danaher acquired Navman Wireless, a provider of on-demand fleet and asset management technology.
In February 2013, Danaher and Cooper Industries sold their joint venture, Apex Tool Group, to Bain Capital for $1.6 billion.
In September 2014, Danaher acquired Nobel Biocare for $2.2 billion.
Effective March 1, 2015, H. Lawrence Culp Jr. resigned as CEO of Danaher.
In July 2015, Danaher combined its communications unit with NetScout Systems.
In August 2015, Danaher acquired Pall Corporation for $13.8 billion.
In June 2016, Danaher completed the corporate spin-off of Fortive, which included Matco and AMMCO-COATS. In September of the same year, the company announced it would acquire Cepheid for $4 billion including debt.
In October 2016, Danaher acquired Phenomenex for $700 million to expand in life sciences.
In October 2017, Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS). IDBS became part of Danaher's Life Sciences platform.
In March 2018, Danaher acquired Integrated DNA Technologies for an estimated $1.9 billion.
In July 2018, Danaher announced its intention to spin off its Dental segment into a public company, later named Envista Holdings Corporation. The corporate spin-off was completed in December 2019.
In March 2020, Integrated DNA Technologies, a subsidiary of the company, manufactured components for COVID-19 testing.
In March 2020, Danaher acquired the biopharma business of General Electric, a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing, for $21.4 billion and was rebranded as Cytiva. The GE deal raised monopoly concerns. The Federal Trade Commission conditionally approved the deal on the grounds that Danaher sold some biotechnology assets. In a second deal, Danaher's biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses were sold to Sartorius AG for approximately $825 million. The Cytiva name is derived from 'cyto' meaning 'cell' in Greek, and 'iva' a Latin suffix meaning 'doing' and 'capable of'.
Effective September 2020, Tom Joyce retired as CEO of the company; he was replaced by Executive Vice President Rainer Blair.
2021–present
In June 2021, Precision Nanosystems was acquired by Cytiva.
In August 2021, Danaher acquired Aldevron, which produces mRNA and proteins used in mRNA vaccines, for $9.6 billion in cash.
In May 2023, Pall Corporation merged with Cytiva to create a new Biotechnology Group within Danaher; at that time Cytiva employed more than 16,000 associates in over 40 countries.
Also in September 2022, Danaher announced its intention to spin off its Environmental & Applied Solutions segment; in February 2023, it was named Veralto and the corporate spin-off was completed in September 2023. The division included Aquatic Informatics, ChemTreat, Esko, Hach Company, Linx, McCrometer, OTT HydroMet, Pantone, Sea-Bird Scientific, Trojan Technologies, Videojet, XOS, and X-Rite.
In December 2023, Danaher acquired Abcam for approximately $5.7 billion.
In June 2024, the Food and Drug Administration granted marketing approval to Danaher's Cepheid unit for a rapid test for hepatitis C. Using a blood sample from a fingertip, the rapid test detects the virus's RNA and delivers results in less than roughly an hour, as opposed to requiring a sample to be sent to a lab.
In August 2024, the company acquired GeneData. In February 2026, Danaher announced it would acquire Masimo for $10 billion.
Divisions
Life sciences
Abcam
Beckman Coulter - Life Sciences
Cytiva
Integrated DNA Technologies
Leica Microsystems
Molecular Devices
Pall Corporation
SCIEX
Diagnostics
Beckman Coulter - Diagnostics
Cepheid
Leica Biosystems
Radiometer
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | DHR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 38.0średnia z 5 lat ≈36.6 | ≈36.6 | 32.0 | Zawyżona wycena | |
| P/S (TTM) | 6.0średnia z 5 lat ≈7.1 | ≈7.1 | 5.4 | Wartość godziwa | |
| P/B (MRQ) | 2.9średnia z 5 lat ≈3.5 | ≈3.5 | 6.9 | Niedowartościowany | |
| Cena / FCF (TTM) | 27.5średnia z 5 lat ≈28.9 | ≈28.9 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 22.7średnia z 5 lat ≈23.8 | ≈23.8 | 25.7 | Wartość godziwa | |
| Cena / Wartość księgowa materialna (MRQ) | 4.8 | · | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈58.4 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | DHR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 58.5%średnia z 5 lat ≈59.7% | ≈59.7% | 57.6% | Zgodnie z | |
| Marża Operacyjna (TTM) | 20.4%średnia z 5 lat ≈22.8% | ≈22.8% | 18.0% | Zgodnie z | |
| EBITDA Margin (Marża EBITDA) | 19.1%średnia z 5 lat ≈27.5% | ≈27.5% | 18.3% | Słaby | |
| Marża przed opodatkowaniem (TTM) | 19.0%średnia z 5 lat ≈22.0% | ≈22.0% | 18.9% | Zgodnie z | |
| Marża Zysku Netto (TTM) | 15.9%średnia z 5 lat ≈19.1% | ≈19.1% | 15.8% | Słaby | |
| ROA (TTM) | 4.6%średnia z 5 lat ≈6.3% | ≈6.3% | 11.5% | Słaby | |
| ROE (TTM) | 7.6%średnia z 5 lat ≈10.8% | ≈10.8% | 18.4% | Słaby | |
| ROIC | 5.6%średnia z 5 lat ≈7.7% | ≈7.7% | 13.8% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | DHR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.5średnia z 5 lat ≈0.4 | ≈0.4 | 0.4 | Wysokie zadłużenie | |
| Wskaźnik bieżący (MRQ) | 1.7średnia z 5 lat ≈1.7 | ≈1.7 | 1.7 | Zgodnie z | |
| Quick Ratio (Wskaźnik Szybkości) | 0.6średnia z 5 lat ≈0.5 | ≈0.5 | 0.8 | Niska płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.5średnia z 5 lat ≈0.4 | ≈0.4 | 0.4 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | DHR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 2.9%średnia z 5 lat ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -2.7%średnia z 5 lat ≈-0.53% | ≈-0.53% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 2.0% | · | · | · | |
| EPS YoY | -4.5%średnia z 5 lat ≈6.5% | ≈6.5% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -7.3%średnia z 5 lat ≈5.8% | ≈5.8% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | -19.4%średnia z 5 lat ≈-8.4% | ≈-8.4% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 0.65% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | -20.6%średnia z 5 lat ≈-8.9% | ≈-8.9% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -0.18% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | DHR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.3średnia z 5 lat ≈0.3 | ≈0.3 | 0.6 | Słaby | |
| Inventory Turnover (Rotacja zapasów) | 4.2średnia z 5 lat ≈4.1 | ≈4.1 | 3.3 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 6.6średnia z 5 lat ≈6.5 | ≈6.5 | 5.3 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$423.6K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 30, 2026 | $0,40 | USD | ≈0.69% |
| Cze 26, 2026 | $0,40 | USD | ≈0.73% |
| Mar 27, 2026 | $0,40 | USD | ≈0.75% |
| Gru 26, 2025 | $0,32 | USD | ≈0.56% |
| Wrz 26, 2025 | $0,32 | USD | ≈0.67% |
| Cze 27, 2025 | $0,32 | USD | ≈0.59% |
| Mar 28, 2025 | $0,32 | USD | ≈0.55% |
| Gru 27, 2024 | $0,27 | USD | ≈0.47% |
| Wrz 27, 2024 | $0,27 | USD | ≈0.38% |
| Cze 28, 2024 | $0,27 | USD | ≈0.42% |
| Mar 27, 2024 | $0,27 | USD | ≈0.41% |
| Gru 28, 2023 | $0,24 | USD | ≈0.42% |
| Paź 11, 2023 | $0,27 | USD | ≈0.45% |
| Cze 29, 2023 | $0,24 | USD | ≈0.44% |
| Mar 30, 2023 | $0,24 | USD | ≈0.41% |
| Gru 29, 2022 | $0,22 | USD | ≈0.37% |
| Wrz 29, 2022 | $0,22 | USD | ≈0.37% |
| Cze 23, 2022 | $0,22 | USD | ≈0.36% |
| Mar 24, 2022 | $0,22 | USD | ≈0.31% |
| Gru 29, 2021 | $0,19 | USD | ≈0.26% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 20, 2026 | $1.94 | $1.85 | 4.7% |
| 31 marca 2026 | $2.06 | $1.96 | 5.3% | |
| 31 grudnia 2025 | $2.23 | $2.17 | 2.6% | |
| 30 września 2025 | $1.89 | $1.74 | 8.7% | |
| 30 czerwca 2025 | $1.80 | $1.66 | 8.4% | |
| 31 marca 2025 | $1.88 | $1.66 | 13.3% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Cost of Revenue | $10.04B | $9.67B | $9.86B | $10.46B | $9.56B | $9.81B | $7.93B | $7.54B | $6.95B | $7.55B | $6.66B | $6.02B | |
| Gross Profit | $14.52B | $14.21B | $14.03B | $16.19B | $15.24B | $12.47B | $9.98B | $9.51B | $8.57B | $9.33B | $7.77B | $6.85B | |
| R&D Expense | $1.60B | $1.58B | $1.50B | $1.53B | $1.50B | $1.35B | $1.13B | $1.06B | $956M | $975M | $861M | $769M | |
| SG&A Expense | $8.23B | $7.76B | $7.33B | $7.12B | $6.82B | $6.90B | $5.59B | $5.39B | $5.04B | $5.62B | $4.75B | $4.04B | |
| Operating Income | $4.69B | $4.86B | $5.20B | $7.54B | $6.38B | $4.23B | $3.27B | $3.06B | $2.57B | $2.74B | $2.16B | $2.04B | |
| Interest Expense | · | · | $286M | $204M | $231M | $275M | $108M | $137M | $140M | $184M | $140M | $95M | |
| Interest Income | $30M | $117M | $303M | $41M | $11M | $71M | $139M | $9M | $8M | $200.0K | $5M | $13M | |
| Other Non-op | $-222M | $-56M | $-175M | $-227M | $450M | $494M | $12M | $35M | · | · | · | · | |
| Pretax Income | $4.23B | $4.65B | $5.04B | $7.15B | $6.51B | $4.50B | $3.31B | $2.96B | $2.54B | $2.61B | $2.04B | $2.09B | |
| Income Tax | $633M | $747M | $823M | $818M | $1.06B | $849M | $873M | $556M | $371M | $458M | $293M | $448M | |
| Net Income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| EPS (Basic) | $5.07 | $5.33 | $6.44 | $9.80 | $8.77 | $4.97 | $4.11 | $3.78 | $3.58 | $3.69 | $4.81 | $3.70 | |
| EPS (Diluted) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 | |
| Shares (Basic) | 712,700,000 | 731,000,000 | 736,500,000 | 725,100,000 | 714,600,000 | 706,200,000 | 715,000,000 | 700,600,000 | 695,800,000 | 691,200,000 | 698,100,000 | 702,200,000 | |
| Shares (Diluted) | 716,100,000 | 737,200,000 | 743,100,000 | 737,100,000 | 736,800,000 | 718,700,000 | 725,500,000 | 710,200,000 | 706,100,000 | 699,800,000 | 708,500,000 | 716,100,000 | |
| EBITDA | $4.69B | $4.86B | $7.37B | $10.91B | $9.63B | $6.01B | $4.46B | $4.71B | $4.26B | $3.88B | $4.52B | $4.37B |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | $19.91B | $788M | $630M | $964M | $791M | $3.01B | |
| Receivables | $3.91B | $3.54B | $3.92B | $4.10B | $4.63B | $4.04B | $3.19B | $3.03B | $3.52B | $3.19B | $2.99B | $3.45B | |
| Inventory | $2.49B | $2.33B | $2.59B | $2.77B | $2.77B | $2.29B | $1.63B | $1.63B | $1.84B | $1.71B | $1.57B | $1.78B | |
| Prepaid Expense | $1.74B | $1.55B | $1.56B | $1.74B | $1.66B | $1.43B | $865M | $858M | $857M | $806M | $890M | $953M | |
| Current Assets | $12.76B | $9.50B | $13.94B | $15.88B | $11.65B | $13.80B | $25.60B | $7.09B | $6.85B | $6.67B | $7.84B | $9.43B | |
| PP&E (Net) | $5.53B | $4.99B | $4.55B | $3.71B | $3.53B | $3.26B | $2.30B | $2.25B | $2.22B | $2.35B | $2.30B | $1.67B | |
| PP&E (Gross) | $10.30B | $9.09B | $8.38B | $7.14B | $7.25B | $6.44B | $5.06B | $4.70B | $4.97B | $4.32B | $3.99B | $4.71B | |
| Accum. Depreciation | $4.77B | $4.10B | $3.83B | $3.43B | $3.46B | $3.18B | $2.76B | $2.45B | $2.52B | $1.96B | $1.69B | $2.54B | |
| Goodwill | $43.15B | $40.50B | $41.61B | $37.28B | $38.68B | $35.42B | $22.71B | $22.58B | $21.77B | $23.83B | $21.01B | $11.58B | |
| Intangibles | $17.82B | $18.57B | $20.75B | $19.82B | $22.84B | $21.28B | $9.75B | $10.28B | $11.67B | $11.82B | $10.55B | $7.06B | |
| Other Non-current Assets | $4.21B | $3.99B | $3.64B | $4.16B | $3.72B | $2.40B | $1.72B | $571M | $538M | $631M | $845M | $1.02B | |
| Total Assets | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Accrued Liabilities | $4.96B | $4.54B | $4.81B | $4.82B | $5.56B | $5.34B | $3.21B | $2.69B | $3.09B | $2.79B | $2.61B | $3.19B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $765M | |
| Current Liabilities | $6.81B | $6.80B | $8.27B | $8.39B | $8.14B | $7.40B | $4.93B | $4.84B | $4.79B | $6.87B | $6.17B | $5.40B | |
| Capital Leases | $1.08B | $968M | $954M | $772M | $889M | $785M | $639M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $5.70B | $5.69B | $6.02B | $6.50B | $7.70B | $7.79B | $5.35B | $4.70B | $5.16B | $5.67B | $5.75B | $4.58B | |
| Long-term Debt | $18.42B | $16.00B | $18.40B | $19.68B | $22.18B | $21.20B | $21.73B | $9.74B | $10.52B | $12.27B | $12.87B | $3.47B | |
| Total Debt | $18.42B | $15.50B | $16.71B | $19.09B | $22.17B | $21.19B | $21.52B | $9.69B | $10.33B | $9.67B | $12.03B | $4.17B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Retained Earnings | $46.89B | $44.19B | $41.07B | $39.20B | $32.83B | $27.16B | $24.17B | $25.16B | $22.81B | $20.70B | $21.01B | $20.32B | |
| Treasury Stock | $11.35B | $8.16B | $2.02B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-207M | $-3.22B | $-1.75B | $-2.87B | $-1.03B | $-368M | $-3.07B | $-2.79B | $-2.15B | $-3.02B | $-2.31B | $-1.43B | |
| Stockholders' Equity | $52.53B | $49.54B | $53.49B | $50.08B | $45.17B | $39.77B | $30.27B | $28.21B | $26.36B | $23.00B | $23.69B | $23.38B | |
| Liabilities + Equity | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Shares Outstanding | 706,900,000 | 719,100,000 | 739,200,000 | 728,300,000 | 715,000,000 | 711,000,000 | 695,500,000 | 701,500,000 | 696,600,000 | 692,200,000 | 686,800,000 | 704,300,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2.17B | $2.13B | $2.06B | $1.77B | $1.19B | $1.18B | $1.12B | $1.13B | $881M | $718M | |
| Stock-based Comp | $298M | $288M | $306M | $295M | $184M | $187M | $159M | $138M | $127M | $130M | $104M | $85M | |
| Amort. of Intangibles | $1.70B | $1.63B | $1.49B | $1.43B | $1.39B | $1.14B | $625M | $616M | $579M | $583M | $397M | $269M | |
| Restructuring | · | · | · | · | · | · | · | $70M | $159M | $152M | $98M | $102M | |
| Other Non-cash | · | · | $-72M | $-1.25B | $-461M | $600M | $-405M | $-88M | $-392M | $-290M | $-746M | $100M | |
| Operating Cash Flow | $6.42B | $6.69B | $7.16B | $8.52B | $8.36B | $6.21B | $3.95B | $4.02B | $3.48B | $3.52B | $3.80B | $3.76B | |
| CapEx | $1.16B | $1.39B | $1.38B | $1.12B | $1.24B | $791M | $636M | $584M | $571M | $590M | $513M | $465M | |
| Investing Cash Flow | $-1.20B | $-1.98B | $-7.08B | $-2.23B | $-12.99B | $-21.24B | $-1.24B | $-2.95B | $-843M | $-5.24B | $-14.95B | $-3.44B | |
| Debt Issued | · | · | · | · | · | · | $12.11B | $0 | $1.78B | $3.24B | $5.68B | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $10.55B | $-508M | $1.11B | $760M | $5.65B | $-415M | |
| Stock Issued | · | · | · | $0 | $0 | $1.73B | $1.44B | $0 | $0 | $164M | $249M | $133M | |
| Stock Repurchased | $3.09B | $5.98B | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | $-3.09B | $-5.98B | · | $0 | $0 | $1.73B | $1.44B | $96M | $69M | $164M | $249M | $133M | |
| Dividends Paid | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M | |
| Financing Cash Flow | $-2.96B | $-8.38B | $-273M | $-2.57B | $1.29B | $1.01B | $16.36B | $-797M | $-3.10B | $2.04B | $9.05B | $-218M | |
| Net Change in Cash | $2.54B | $-3.79B | $-131M | $3.41B | $-3.45B | $-13.88B | $19.12B | $158M | $-333M | $173M | $-2.21B | $-110M | |
| Taxes Paid | $1.20B | $1.30B | $1.80B | $1.80B | $1.70B | · | · | · | · | · | · | · | |
| Free Cash Flow | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B | $5.42B | $3.32B | $3.37B | $2.86B | $2.93B | $3.17B | $3.16B | |
| Levered FCF | · | · | $5.54B | $7.18B | $6.87B | $5.19B | $3.24B | $3.24B | $2.72B | $2.78B | $3.04B | $3.07B |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% | 56.0% | 55.7% | 55.8% | 55.6% | 55.3% | 52.3% | 52.4% | |
| Operating Margin | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% | 19.0% | 18.2% | 17.1% | 16.5% | 16.3% | 16.9% | 17.2% | |
| Net Margin | 14.7% | 16.3% | 19.9% | 22.9% | 21.8% | 16.4% | 16.8% | 13.3% | 13.6% | 15.1% | 16.3% | 13.1% | |
| Pretax Margin | 17.2% | 19.5% | 21.1% | 26.4% | 25.8% | 20.2% | 18.4% | 16.6% | 16.0% | 15.5% | 16.2% | 17.5% | |
| EBITDA Margin | 19.1% | 20.4% | 30.8% | 34.7% | 32.7% | 27.0% | 24.9% | 23.7% | 23.2% | 23.0% | 22.0% | 21.9% | |
| ROA | 4.5% | 4.8% | 5.6% | 8.6% | 8.1% | 5.3% | 5.5% | 5.6% | 5.4% | 5.5% | 7.9% | 7.2% | |
| ROE | 7.1% | 7.6% | 9.2% | 15.1% | 15.2% | 10.4% | 10.3% | 9.7% | 10.1% | 10.9% | 14.3% | 11.4% | |
| ROIC | 5.6% | 6.3% | 6.2% | 10.9% | 9.3% | 5.6% | 4.7% | 7.2% | 6.9% | 6.9% | 7.6% | 9.3% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 | 1.9 | 5.2 | 1.5 | 1.4 | 1.0 | 1.3 | 1.7 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 4.7 | 0.9 | 0.9 | 0.6 | 0.8 | 1.2 | |
| Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.2 | |
| LT Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.1 | |
| Interest Coverage | · | · | 18.2 | 41.2 | 31.4 | 15.4 | 30.1 | 21.6 | 18.6 | 14.9 | 21.3 | 28.0 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | |
| Inventory Turnover | 4.2 | 3.9 | 3.7 | 4.3 | 4.5 | 5.0 | 4.9 | 4.7 | 4.6 | 4.6 | 5.1 | 5.2 | |
| Receivables Turnover | 6.6 | 6.4 | 6.0 | 6.6 | 6.8 | 6.2 | 5.8 | 5.7 | 5.5 | 5.5 | 5.6 | 5.6 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $74.32 | $68.90 | $72.36 | $68.77 | $63.17 | $55.93 | $43.52 | $40.22 | $37.84 | $33.23 | $34.49 | $33.19 | |
| Revenue / Share | $34.31 | $32.39 | $32.15 | $42.70 | $39.97 | $31.01 | $24.69 | $28.01 | $25.96 | $24.12 | $29.02 | $27.81 | |
| Cash Flow / Share | $8.96 | $9.07 | $9.64 | $11.56 | $11.34 | $8.64 | $5.45 | $5.66 | $4.93 | $5.03 | $5.37 | $5.25 | |
| Cash / Share | · | · | · | · | · | · | $28.63 | $1.12 | $0.90 | $1.39 | $1.15 | $4.27 | |
| EPS (TTM) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.9% | -0.06% | -10.3% | 7.4% | 11.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.7% | -1.3% | 2.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.5% | -17.1% | -34.0% | 12.2% | 76.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -19.4% | -15.0% | 9.3% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.65% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -7.3% | -18.2% | -33.9% | 12.1% | 76.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -20.6% | -15.4% | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.18% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 7.4% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Net Income TTM | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| Market Cap | $161.82B | $165.07B | $171.01B | $171.37B | $208.55B | $140.02B | $94.63B | $64.13B | $57.32B | $47.77B | $56.55B | $53.52B | |
| Enterprise Value | · | · | · | · | · | · | $96.24B | $73.03B | $67.02B | $56.48B | $67.79B | $54.68B | |
| P/E | 45.3 | 43.4 | 36.3 | 24.4 | 33.9 | 40.3 | 33.6 | 24.4 | 23.3 | 18.9 | 17.4 | 20.9 | |
| P/S | 6.6 | 6.9 | 7.2 | 6.4 | 8.4 | 6.3 | 5.3 | 3.8 | 3.7 | 2.8 | 3.9 | 4.2 | |
| P/B | 3.1 | 3.3 | 3.2 | 3.4 | 4.6 | 3.5 | 3.1 | 2.3 | 2.2 | 2.1 | 2.4 | 2.3 | |
| P / Cash Flow | 25.2 | 24.7 | 23.9 | 20.1 | 25.0 | 22.6 | 23.9 | 15.9 | 16.5 | 13.6 | 14.9 | 14.2 | |
| P / FCF | 30.8 | 31.2 | 29.6 | 23.3 | 29.5 | 25.8 | 28.5 | 19.1 | 20.1 | 16.3 | 17.8 | 16.9 | |
| EV / EBITDA | · | · | · | · | · | · | 21.6 | 15.5 | 15.7 | 14.6 | 15.0 | 12.5 | |
| EV / FCF | · | · | · | · | · | · | 29.0 | 21.7 | 23.4 | 19.3 | 21.4 | 17.3 | |
| EV / Revenue | · | · | · | · | · | · | 5.4 | 4.3 | 4.3 | 3.3 | 4.7 | 4.2 | |
| Dividend Yield | 0.54% | 0.47% | 0.48% | 0.48% | 0.36% | 0.44% | 0.56% | 0.68% | 0.66% | 0.84% | 0.63% | 0.43% | |
| Earnings Yield | 2.2% | 2.3% | 2.8% | 4.1% | 2.9% | 2.5% | 3.0% | 4.1% | 4.3% | 5.3% | 5.8% | 4.8% | |
| Payout Ratio | 24.3% | 19.7% | 17.2% | 11.3% | 11.5% | 16.9% | 17.5% | 16.4% | 15.2% | 15.7% | 10.5% | 8.8% | |
| Annual Payout | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | $5.74B | $6.54B | $5.80B | $5.74B | $5.80B | $6.41B | $5.62B | $5.91B | $5.95B | $3.54B | $6.46B | |
| Cost of Revenue | $2.65B | $2.36B | $2.87B | $2.53B | $2.41B | $2.23B | $2.65B | $2.40B | $2.31B | $2.31B | $2.63B | $2.35B | $2.59B | $2.29B | $1.36B | $3.08B | |
| Gross Profit | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | $3.51B | $3.89B | $3.40B | $3.43B | $3.49B | $3.78B | $3.27B | $3.32B | $3.66B | $2.18B | $3.89B | |
| R&D Expense | $412M | $387M | $438M | $378M | $403M | $379M | $442M | $383M | $391M | $368M | $407M | $362M | $361M | $373M | $236M | $420M | |
| SG&A Expense | $2.07B | $1.86B | $2.03B | $1.99B | $2.36B | $1.86B | $2.02B | $2.06B | $1.87B | $1.81B | $2.04B | $1.73B | $1.79B | $1.77B | $798M | $2.15B | |
| Operating Income | $1.13B | $1.34B | $1.50B | $1.15B | $760M | $1.27B | $1.43B | $958M | $1.17B | $1.31B | $1.34B | $1.19B | $1.16B | $1.52B | $1.14B | $1.72B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $65M | · | $73M | $67M | $66M | · | $42M | |
| Interest Income | $61M | $27M | $13M | $3M | $8M | $6M | $14M | $4M | $39M | $60M | $117M | $79M | $59M | $48M | $29M | $9M | |
| Other Non-op | $-3M | $-73M | $-87M | $-14M | $-42M | $-79M | $-63M | $102M | $-59M | $-36M | $-137M | $-47M | $-15M | $24M | $-69M | $-51M | |
| Pretax Income | $1.08B | $1.24B | $1.37B | $1.08B | $655M | $1.13B | $1.31B | $977M | $1.08B | $1.27B | $1.23B | $1.15B | $1.14B | $1.52B | $1.05B | $1.93B | |
| Income Tax | $208M | $206M | $190M | $168M | $100M | $175M | $229M | $159M | $176M | $183M | $111M | $207M | $222M | $283M | $-304M | $359M | |
| Net Income | $870M | $1.03B | $1.20B | $908M | $555M | $954M | $1.09B | $818M | $907M | $1.09B | $1.08B | $1.13B | $1.11B | $1.45B | $2.23B | $1.57B | |
| EPS (Basic) | $1.23 | $1.45 | $1.69 | $1.28 | $0.77 | $1.33 | $1.50 | $1.13 | $1.23 | $1.47 | $1.45 | $1.53 | $1.50 | $1.96 | $3.04 | $2.13 | |
| EPS (Diluted) | $1.23 | $1.45 | $1.69 | $1.27 | $0.77 | $1.32 | $1.50 | $1.12 | $1.22 | $1.45 | $1.44 | $1.51 | $1.49 | $1.94 | $2.99 | $2.10 | |
| Shares (Basic) | 705,300,000 | 707,900,000 | · | 710,700,000 | 716,500,000 | 716,300,000 | · | 723,000,000 | 737,600,000 | 740,600,000 | · | 739,400,000 | 737,300,000 | 729,400,000 | · | 728,500,000 | |
| Shares (Diluted) | 707,600,000 | 711,200,000 | · | 713,700,000 | 719,100,000 | 720,800,000 | · | 729,400,000 | 742,400,000 | 748,600,000 | · | 745,900,000 | 744,700,000 | 737,200,000 | · | 737,400,000 | |
| EBITDA | · | $1.34B | · | $1.15B | $760M | $1.27B | · | $958M | $1.17B | $1.31B | · | $1.44B | $1.43B | $1.79B | · | $2.02B |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3.96B | $3.82B | $3.91B | $3.75B | $3.56B | $3.51B | $3.54B | $3.51B | $3.30B | $3.38B | · | $4.20B | $4.20B | $4.31B | · | $4.41B | |
| Inventory | $3.26B | $2.61B | $2.49B | $2.67B | $2.69B | $2.53B | $2.33B | $2.68B | $2.67B | $2.65B | · | $3.02B | $3.18B | $3.38B | · | $3.24B | |
| Prepaid Expense | $1.81B | $1.81B | $1.74B | $1.65B | $1.79B | $1.49B | $1.55B | $1.25B | $1.27B | $1.32B | · | $1.70B | $1.50B | $1.46B | · | $1.46B | |
| Current Assets | $13.38B | $13.94B | $12.76B | $9.61B | $11.00B | $9.53B | $9.50B | $10.06B | $9.61B | $14.37B | · | $21.20B | $17.46B | $16.53B | · | $14.25B | |
| PP&E (Net) | $5.83B | $5.47B | $5.53B | $5.38B | $5.31B | $5.11B | $4.99B | $4.84B | $4.64B | $4.56B | $4.55B | $4.30B | $4.18B | $4.07B | $3.71B | $3.72B | |
| PP&E (Gross) | · | · | $10.30B | · | · | · | $9.09B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.92B | $4.83B | $4.77B | $4.67B | $4.56B | $4.31B | $4.10B | $4.20B | $4.05B | $3.96B | · | $4.12B | $4.12B | $4.02B | · | $3.63B | |
| Goodwill | $47.41B | $42.77B | $43.15B | $42.95B | $42.99B | $41.66B | $40.50B | $42.17B | $40.80B | $40.85B | $41.61B | $39.16B | $39.58B | $39.86B | $37.28B | $38.25B | |
| Intangibles | $21.36B | $17.17B | $17.82B | $18.10B | $18.63B | $18.89B | $18.57B | $19.85B | $19.55B | $19.89B | · | $18.79B | $19.32B | $19.98B | · | $19.96B | |
| Other Non-current Assets | $4.39B | $4.21B | $4.21B | $3.87B | $3.69B | $3.94B | $3.99B | $3.69B | $3.95B | $3.73B | · | $4.29B | $4.37B | $4.61B | · | $4.85B | |
| Total Assets | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | $84.49B | $87.73B | $84.90B | $85.04B | $84.35B | $81.03B | |
| Accrued Liabilities | $4.87B | $4.75B | $4.96B | $4.60B | $4.57B | $4.42B | $4.54B | $4.54B | $4.36B | $4.35B | · | $4.93B | $4.86B | $5.08B | · | $5.11B | |
| Current Liabilities | $8.11B | $7.46B | $6.81B | $6.32B | $6.79B | $6.64B | $6.80B | $7.34B | $6.70B | $7.78B | · | $9.37B | $8.40B | $8.73B | · | $8.00B | |
| Capital Leases | · | · | $1.08B | · | · | · | $968M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $6.52B | $5.57B | $5.70B | $5.66B | $5.63B | $5.64B | $5.69B | $5.65B | $5.64B | $5.76B | · | $6.44B | $6.49B | $6.56B | · | $7.49B | |
| Long-term Debt | $26.56B | $18.48B | $18.42B | $16.86B | $17.36B | $16.48B | $16.00B | $17.52B | $17.01B | $18.16B | · | $22.06B | $19.88B | $19.83B | · | $19.25B | |
| Total Debt | · | $17.56B | · | $16.83B | $16.85B | $15.98B | · | $16.32B | $16.31B | $16.42B | · | $19.51B | $18.29B | $18.26B | · | $18.54B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Retained Earnings | $48.23B | $47.64B | $46.89B | $45.92B | $45.24B | $44.91B | $44.19B | $43.30B | $42.67B | $41.96B | · | $42.27B | $41.34B | $40.44B | · | $37.18B | |
| Treasury Stock | $12.32B | $11.41B | $11.35B | $11.34B | $9.30B | $9.31B | $8.16B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-795M | $-593M | $-207M | $-590M | $-569M | $-1.61B | $-3.22B | $-1.31B | $-2.59B | $-2.74B | · | $-3.96B | $-3.58B | $-2.77B | $-2.87B | $-3.85B | |
| Stockholders' Equity | $52.58B | $52.95B | $52.53B | $51.07B | $52.33B | $50.85B | $49.54B | $51.30B | $49.90B | $53.44B | · | $52.41B | $51.72B | $51.48B | · | $46.98B | |
| Liabilities + Equity | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | · | $87.73B | $84.90B | $85.04B | · | $81.03B | |
| Shares Outstanding | 702,900,000 | 707,700,000 | 706,900,000 | 706,300,000 | 715,900,000 | 715,600,000 | 719,100,000 | 722,200,000 | 724,000,000 | 740,600,000 | · | 738,900,000 | 738,200,000 | 729,200,000 | · | 727,900,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $93M | $58M | $63M | $83M | $91M | $61M | $57M | $84M | $87M | $60M | $61M | $57M | $87M | $70M | $25M | $89M | |
| Amort. of Intangibles | $463M | $434M | $428M | $433M | $426M | $410M | $408M | $414M | $402M | $407M | $380M | $343M | $360M | $372M | $314M | $361M | |
| Operating Cash Flow | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | $1.30B | $2.02B | $1.51B | $1.42B | $1.74B | $1.62B | $1.67B | $1.93B | $1.95B | $2.54B | $2.01B | |
| CapEx | $269M | $237M | $371M | $292M | $248M | $245M | $516M | $298M | $287M | $291M | $434M | $333M | $320M | $266M | $295M | $277M | |
| Investing Cash Flow | $-10.15B | $-249M | $-384M | $-312M | $-258M | $-242M | $-694M | $-606M | $-360M | $-321M | $-6.02B | $-329M | $-431M | $-304M | $-816M | $-515M | |
| Stock Repurchased | $894M | $0 | $0 | $2.01B | $0 | $1.08B | $809M | $640M | $4.53B | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-1.08B | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $283M | $226M | $226M | $229M | $229M | $194M | $195M | $196M | $200M | $177M | $200M | $199M | $218M | $204M | $203M | $204M | |
| Financing Cash Flow | $7.27B | $46M | $1.32B | $-2.78B | $-247M | $-1.25B | $-1.69B | $-845M | $-5.71B | $-133M | $-2.25B | $2.44B | $-208M | $-262M | $-906M | $-230M | |
| Net Change in Cash | $-1.35B | $1.09B | $3.09B | $-1.43B | $964M | $-85M | $-549M | $253M | $-4.66B | $1.17B | $-6.41B | $3.70B | $1.20B | $1.38B | $845M | $1.17B | |
| Taxes Paid | $350M | $191M | $392M | $277M | $330M | $201M | $367M | $315M | $396M | $222M | $630M | $476M | $466M | $228M | $706M | $469M | |
| Free Cash Flow | · | $1.08B | · | · | · | $1.05B | · | · | · | $1.45B | · | · | · | $1.67B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.39B | · | · | · | $1.62B | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 60.3% | · | 58.2% | 59.4% | 61.2% | · | 58.7% | 59.7% | 60.2% | · | 58.2% | 56.5% | 61.0% | · | 59.8% | |
| Operating Margin | · | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| Net Margin | 13.9% | 17.3% | · | 15.0% | 9.3% | 16.6% | · | 14.1% | 15.8% | 18.8% | · | 16.4% | 15.4% | 20.2% | · | 20.5% | |
| Pretax Margin | 17.2% | 20.8% | · | 17.8% | 11.0% | 19.7% | · | 16.9% | 18.9% | 21.9% | · | 20.3% | 19.4% | 25.1% | · | 25.2% | |
| EBITDA Margin | 18.0% | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| ROA | 1.0% | 1.3% | · | 1.1% | 0.69% | 1.2% | · | 0.97% | 1.1% | 1.3% | · | 1.3% | 1.3% | 1.7% | · | 1.9% | |
| ROE | 1.7% | 2.0% | · | 1.8% | 1.1% | 1.8% | · | 1.6% | 1.8% | 2.1% | · | 2.3% | 2.2% | 3.0% | · | 3.5% | |
| ROIC | 1.2% | 1.6% | · | 1.4% | 0.93% | 1.6% | · | 1.2% | 1.5% | 1.6% | · | 1.6% | 1.6% | 2.1% | · | 2.5% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.5 | 1.6 | 1.4 | · | 1.4 | 1.4 | 1.8 | · | 2.3 | 2.1 | 1.9 | · | 1.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 20.2 | · | 19.7 | 21.3 | 26.4 | · | 48.0 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | 0.9 | · | 1.2 | |
| Receivables Turnover | · | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.8 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $74.81 | $74.82 | · | $72.31 | $73.10 | $71.06 | · | $71.03 | $68.92 | $72.16 | · | $70.93 | $70.06 | $70.60 | · | $64.55 | |
| Revenue / Share | $8.85 | $8.37 | · | $8.48 | $8.25 | $7.96 | · | $7.95 | $7.74 | $7.74 | · | $9.21 | $9.61 | $9.72 | · | $10.39 | |
| Cash Flow / Share | · | $1.86 | · | · | · | $1.80 | · | · | · | $2.32 | · | · | · | $2.64 | · | · | |
| EPS (TTM) | $5.64 | $5.18 | · | $4.86 | $4.71 | $5.16 | · | $5.23 | $5.62 | $5.89 | · | $7.93 | $8.52 | $9.28 | · | $9.05 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $25.11B | $24.78B | · | $24.27B | $24.01B | $23.82B | · | $23.74B | $23.57B | $23.74B | · | $21.03B | $21.86B | $22.47B | · | $23.01B | |
| Net Income TTM | $4.00B | $3.69B | · | $3.50B | $3.41B | $3.77B | · | $3.89B | $4.20B | $4.40B | · | $5.92B | $6.36B | $6.93B | · | $6.76B | |
| Market Cap | $137.90B | $128.46B | · | $130.55B | $142.32B | $147.31B | · | $198.92B | $180.89B | $184.94B | · | $162.52B | $157.06B | $162.93B | · | $166.67B | |
| P/E | 34.8 | 35.0 | · | 38.0 | 42.2 | 39.9 | · | 52.7 | 44.5 | 42.4 | · | 27.7 | 25.0 | 24.1 | · | 25.3 | |
| P/S | 5.5 | 5.2 | · | 5.4 | 5.9 | 6.2 | · | 8.4 | 7.7 | 7.8 | · | 7.7 | 7.2 | 7.3 | · | 7.2 | |
| P/B | 2.6 | 2.4 | · | 2.6 | 2.7 | 2.9 | · | 3.9 | 3.6 | 3.5 | · | 3.1 | 3.0 | 3.2 | · | 3.5 | |
| P / Cash Flow | · | 97.2 | · | · | · | 113.4 | · | · | · | 106.3 | · | · | · | 83.7 | · | · | |
| Dividend Yield | 0.70% | 0.71% | · | 0.65% | 0.57% | 0.53% | · | 0.39% | 0.43% | 0.43% | · | 0.51% | 0.53% | · | · | · | |
| Earnings Yield | 2.9% | 2.9% | · | 2.6% | 2.4% | 2.5% | · | 1.9% | 2.2% | 2.4% | · | 3.6% | 4.0% | 4.2% | · | 4.0% | |
| Payout Ratio | · | 22.0% | · | · | · | 20.3% | · | · | · | 16.3% | · | · | · | 14.1% | · | · | |
| Annual Payout | · | $910M | · | $847M | $814M | $785M | · | $773M | $776M | $794M | · | $824M | $829M | · | · | · |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B |
| Marża Brutto % | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% |
| Marża Operacyjna % | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% |
| Zysk netto | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B |
| Rozwodniony EPS | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 |
| Wskaźnik bieżący | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 |
| Wskaźnik Szybkości | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B |
Właściciele instytucjonalni (13F) 2 317 emitentów · $121.1B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 148 (-60 vs poprzedni kw.) | 182 (-73 vs poprzedni kw.) | 694 (-87 vs poprzedni kw.) | 1 024 (+88 vs poprzedni kw.) | -368K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $13 959 166 172 | 60 978 360 | 11,53% | Akcje |
| BlackRock, Inc. | $10 492 520 322 | 55 084 630 | 8,66% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $7 881 505 437 | 41 377 076 | 6,51% | Akcje |
| FMR LLC | $5 626 949 757 | 29 540 895 | 4,65% | Akcje |
| STATE STREET CORP | $5 431 565 288 | 28 456 019 | 4,49% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $3 108 030 541 | 16 316 834 | 2,57% | Akcje |
| Capital International Investors | $2 953 960 497 | 15 504 420 | 2,44% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $2 707 246 740 | 14 280 335 | 2,24% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 705 808 973 | 14 205 213 | 2,23% | Akcje |
| JPMORGAN CHASE & CO | $2 349 101 825 | 12 185 400 | 1,94% | Akcje |
| MORGAN STANLEY | $2 161 750 127 | 11 348 958 | 1,79% | Akcje |
| Capital Research Global Investors | $2 060 650 455 | 10 818 030 | 1,70% | Akcje |
| NORGES BANK | $1 816 780 335 | 9 537 906 | 1,50% | Akcje |
| EAGLE CAPITAL MANAGEMENT LLC | $1 783 176 557 | 9 361 490 | 1,47% | Akcje |
| NORTHERN TRUST CORP | $1 319 158 000 | 6 925 441 | 1,09% | Akcje |
| GENERATION INVESTMENT MANAGEMENT LLP | $1 287 948 806 | 6 761 596 | 1,06% | Akcje |
| JANUS HENDERSON GROUP PLC | $1 222 064 214 | 6 489 965 | 1,01% | Akcje |
| GOLDMAN SACHS GROUP INC | $1 021 898 650 | 5 364 861 | 0,84% | Akcje |
| Nuveen, LLC | $998 625 469 | 5 242 679 | 0,82% | Akcje |
| BANK OF AMERICA CORP /DE/ | $993 845 921 | 5 217 586 | 0,82% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $990 823 246 | 5 225 861 | 0,82% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $983 459 478 | 5 163 059 | 0,81% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $979 232 536 | 5 140 868 | 0,81% | Akcje |
| Fisher Asset Management, LLC | $854 260 080 | 4 484 774 | 0,71% | Akcje |
| Legal & General Group Plc | $801 056 220 | 4 205 461 | 0,66% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $762 216 330 | 3 878 641 | 0,63% | Akcje |
| Invesco Ltd. | $753 537 418 | 3 955 992 | 0,62% | Akcje |
| FLOSSBACH VON STORCH SE | $747 259 707 | 3 923 035 | 0,62% | Akcje |
| Bank of New York Mellon Corp | $712 874 853 | 3 742 518 | 0,59% | Akcje |
| FRANKLIN RESOURCES INC | $702 374 137 | 3 687 390 | 0,58% | Akcje |
| PARNASSUS INVESTMENTS, LLC | $699 862 950 | 3 674 207 | 0,58% | Akcje |
| Holocene Advisors, LP | $684 356 163 | 3 592 798 | 0,57% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $674 795 972 | 3 542 608 | 0,56% | Akcje |
| UBS Group AG | $617 826 451 | 3 243 524 | 0,51% | Akcje |
| Amundi | $549 255 875 | 2 883 536 | 0,45% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $507 487 046 | 2 664 239 | 0,42% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $505 131 601 | 2 651 651 | 0,42% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $503 199 762 | 2 641 746 | 0,42% | Akcje |
| BROWN ADVISORY INC | $500 677 350 | 2 628 487 | 0,41% | Akcje |
| ROYAL BANK OF CANADA | $455 982 000 | 2 393 859 | 0,38% | Akcje |
| DEUTSCHE BANK AG\ | $446 265 498 | 2 342 847 | 0,37% | Akcje |
| AMERIPRISE FINANCIAL INC | $444 130 104 | 2 331 466 | 0,37% | Akcje |
| FIL Ltd | $442 569 613 | 2 323 444 | 0,37% | Akcje |
| D1 Capital Partners L.P. | $434 682 789 | 2 282 039 | 0,36% | Akcje |
| FIRST MANHATTAN CO. LLC. | $429 106 102 | 2 248 424 | 0,35% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $410 455 346 | 2 154 842 | 0,34% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $407 739 012 | 2 140 587 | 0,34% | Akcje |
| Castle Hook Partners LP | $404 836 478 | 2 125 349 | 0,33% | Akcje |
| CIBC Private Wealth Group LLC | $402 413 634 | 2 029 727 | 0,33% | Akcje |
| WELLS FARGO & COMPANY/MN | $401 433 291 | 2 107 482 | 0,33% | Akcje |
Aktywiści i właściciele 5%+ 9 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Mitchell P. Rales ×9 zgłoszenia | 2 listopada 2021 | · | Pierwotne zgłoszenie | · | SEC |
| Steven M. Rales ×6 zgłoszenia | 14 czerwca 2021 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 22 października 2014 | · | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Danaher Corporation., Aegean Acquisition Corp. ×2 zgłoszenia | 9 grudnia 2010 | · | Pierwotne zgłoszenie | · | SEC |
| Danaher Corporation, DH Holdings Corp., DH Technologies Development Pte. Ltd. ×3 zgłoszenia | 5 lutego 2010 | · | Pierwotne zgłoszenie | · | SEC |
| Equity Group Holdings LLC, Equity Group Holdings II LLC, Steven M. Rales, Mitchell P. Rales ×6 zgłoszenia | 30 marca 2007 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 23 kwietnia 2003 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 8 czerwca 2001 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 25 maja 2001 | · | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 50 insiderów · 24 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Rainer Blair | President & CEO | 21 sierpnia 2026 S | 0 | 0 | 3 | $-12 736 069 |
| Thomas Patrick Joyce JR | President and CEO | 24 lipca 2020 M | 203 513 | 0 | 0 | $0 |
| Lawrence H Culp JR | President and CEO | 18 lipca 2014 M | 512 199 | 0 | 0 | $0 |
| Georgeann Couchara | SVP, Human Resources | 15 maja 2026 F | 8 291 | 0 | 2 | $-1 088 686 |
| Matthew Mcgrew | Executive Vice President | 1 marca 2026 A | 26 825 | 0 | 1 | $-3 470 835 |
| Bradley R Gray | SVP Strategic Development | 1 marca 2026 A | 14 463 | 0 | 0 | $0 |
| Brian W Ellis | Senior Vice President | 4 lutego 2026 A | 14 994 | 0 | 2 | $-4 773 810 |
| Daniel Raskas | SVP - Corporate Development | 1 lutego 2025 A | 10 524 | 0 | 0 | $0 |
| William King | SVP, Strategic Development | 15 maja 2024 M | 48 190 | 0 | 0 | $0 |
| Joakim Weidemanis | Executive Vice President | 15 maja 2024 F | 87 333 | 0 | 0 | $0 |
| Jennifer Honeycutt | Executive Vice President | 15 maja 2023 F | 26 165 | 0 | 0 | $0 |
| Angela S Lalor | SVP, Human Resources | 24 lutego 2022 A | 47 962 | 0 | 0 | $0 |
| Robert S Lutz | SVP-Chief Accounting Officer | 13 sierpnia 2021 M | 16 155 | 0 | 0 | $0 |
| William K Daniel | EVP | 20 lutego 2020 A | 109 886 | 0 | 0 | $0 |
| James A Lico | Executive Vice President | 10 maja 2016 A | 113 198 | 0 | 0 | $0 |
| Mark A Beck | Executive Vice President | 28 lipca 2015 S | 0 | 0 | 0 | $0 |
| Jonathan P Graham | Senior VP & GC | 19 maja 2015 M | 34 606 | 0 | 0 | $0 |
| James H Ditkoff | Senior VP-Finance & Tax | 21 lutego 2015 F | 174 406 | 0 | 0 | $0 |
| Philip Knisely | Executive Vice President | 29 stycznia 2010 A | 5 010 | 0 | 0 | $0 |
| Steve Simms | Executive Vice President | 26 października 2007 A | 4 400 | 0 | 0 | $0 |
| Patrick W Allender | Executive VP | 1 lutego 2007 M | 75 813 | 0 | 0 | $0 |
| Daniel A Pryor | VP-Strategic Development | 4 maja 2005 A | 0 | 0 | 0 | $0 |
| Donald E Doles | VP-Danaher Business System | 31 sierpnia 2004 A | · | 0 | 0 | $0 |
| Chris Mcmahon | VP -- Controller | 1 stycznia 2004 A | 0 | 0 | 0 | $0 |
| Charles W Lamanna | Dyrektor | 15 maja 2026 A | 1 359 | 0 | 0 | $0 |
| John T Schwieters | Dyrektor | 15 lipca 2025 M | 19 815 | 0 | 0 | $0 |
| Jessica L Mega | Dyrektor | 15 maja 2025 A | 3 302 | 0 | 0 | $0 |
| Pardis C Sabeti | Dyrektor | 25 października 2024 A | 5 283 | 0 | 0 | $0 |
| Walter G Lohr | Dyrektor | 15 lutego 2024 M | 14 129 | 0 | 0 | $0 |
| Donald J Ehrlich | Dyrektor | 10 lutego 2020 M | 123 203 | 0 | 0 | $0 |
| Robert J Hugin | Dyrektor | 15 maja 2017 A | 3 576 | 0 | 0 | $0 |
| Mortimer M Caplin | Dyrektor | 26 kwietnia 2013 A | 83 213 | 0 | 0 | $0 |
| Emmet A Stephenson JR | Dyrektor | 30 listopada 2007 M | 368 240 | 0 | 0 | $0 |
| Matthew E Gugino | · | 4 sierpnia 2026 A | 11 401 | 0 | 0 | $0 |
| Gregory M Milosevich | · | 4 sierpnia 2026 A | 24 467 | 0 | 1 | $-274 573 |
| Montgomery Julie A Sawyer | · | 4 sierpnia 2026 A | 22 221 | 0 | 0 | $0 |
| Christopher Paul Riley | · | 4 sierpnia 2026 A | 61 472 | 0 | 0 | $0 |
| Christopher Bouda | · | 4 sierpnia 2026 A | 9 107 | 0 | 0 | $0 |
| Jose-Carlos Gutierrez-Ramos | · | 4 sierpnia 2026 A | 32 495 | 0 | 0 | $0 |
| Jonathan Leiken | · | 4 sierpnia 2026 A | 12 546 | 0 | 0 | $0 |
| Mitchell P. Rales | · | 4 sierpnia 2026 A | 553 228 | 0 | 9 | $-234 561 260 |
| Steven M Rales | · | 4 sierpnia 2026 A | 3 605 808 | 0 | 0 | $0 |
| Shane A Sanders | · | 31 lipca 2026 A | 5 914 | 0 | 0 | $0 |
| Raymond C Stevens | · | 31 lipca 2026 A | 13 728 | 0 | 0 | $0 |
| Teri List-Stoll | · | 31 lipca 2026 A | 21 470 | 0 | 1 | $-746 997 |
| Feroz Dewan | · | 31 lipca 2026 A | 4 686 | 0 | 0 | $0 |
| Elias A. Zerhouni | · | 31 lipca 2026 A | 45 303 | 0 | 0 | $0 |
| Linda P Hefner | · | 31 lipca 2026 A | 26 829 | 0 | 0 | $0 |
| Alan G Spoon | · | 31 lipca 2026 A | 124 774 | 0 | 1 | $-237 202 |
| Daniel L Comas | · | 23 października 2020 M | 92 683 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 125 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| JXX · Janus Detroit Street Trust | 4,03% | 5 508 NS | 31 lipca 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 3,22% | 235 300 NS | 31 lipca 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2,62% | 29 365 NS | 31 lipca 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,16% | 1 006 NS | 31 lipca 2026 | N-PORT |
| IYH · iShares Trust | 2,04% | 369 897 SH | 11 września 2026 | Dziennie |
| GRW · TCW ETF Trust | 1,92% | 6 380 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,80% | 302 986 NS | 31 lipca 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,79% | 1 914 802 SH | 19 sierpnia 2026 | Dziennie |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,77% | 69 716 SH | 1 października 2026 | Dziennie |
| MEDI · Harbor ETF Trust | 1,73% | 3 647 NS | 31 lipca 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,67% | 5 923 NS | 31 lipca 2026 | N-PORT |
| IXJ · iShares Trust | 1,60% | 331 014 SH | 11 września 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 1,41% | 12 395 NS | 31 lipca 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,30% | 147 190 NS | 31 lipca 2026 | N-PORT |
| NULC · Nushares ETF Trust | 1,15% | 4 154 NS | 31 lipca 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1,13% | 2 932 NS | 31 lipca 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,11% | 137 544 SH | 1 października 2026 | Dziennie |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,10% | 6 377 NS | 31 lipca 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 1,07% | 1 437 NS | 31 lipca 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 1,03% | 96 880 NS | 31 lipca 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,81% | 46 812 NS | 31 lipca 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,79% | 2 199 NS | 31 lipca 2026 | N-PORT |
| XT · iShares Trust | 0,72% | 138 670 SH | 11 września 2026 | Dziennie |
| FFLC · FIDELITY COVINGTON TRUST | 0,59% | 36 489 NS | 31 lipca 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,59% | 165 000 | 1 października 2026 | Dziennie |
| PFM · Invesco Exchange-Traded Fund Trust | 0,58% | 20 005 SH | 1 października 2026 | Dziennie |
| MGV · VANGUARD WORLD FUND | 0,57% | 400 375 SH | 19 sierpnia 2026 | Dziennie |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,52% | 3 558 711 SH | 19 sierpnia 2026 | Dziennie |
| USXF · iShares Trust | 0,51% | 37 795 SH | 11 września 2026 | Dziennie |
| IWX · iShares Trust | 0,47% | 91 310 SH | 11 września 2026 | Dziennie |
| VTV · VANGUARD INDEX FUNDS | 0,45% | 6 058 224 SH | 19 sierpnia 2026 | Dziennie |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,44% | 4 091 NS | 31 lipca 2026 | N-PORT |
| EVUS · iShares Trust | 0,43% | 8 232 SH | 11 września 2026 | Dziennie |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,43% | 23 256 NS | 31 lipca 2026 | N-PORT |
| IVE · iShares Trust | 0,42% | 1 046 214 SH | 11 września 2026 | Dziennie |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,41% | 145 011 SH | 19 sierpnia 2026 | Dziennie |
| IUSV · iShares Trust | 0,40% | 551 533 SH | 11 września 2026 | Dziennie |
| ILCV · iShares Trust | 0,38% | 25 086 SH | 11 września 2026 | Dziennie |
| SUSL · iShares Trust | 0,37% | 22 482 SH | 11 września 2026 | Dziennie |
| CHRI · Global X Funds | 0,37% | 153 NS | 31 lipca 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,37% | 16 067 SH | 1 października 2026 | Dziennie |
| DSI · iShares Trust | 0,36% | 97 358 SH | 11 września 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,35% | 277 749 NS | 31 lipca 2026 | N-PORT |
| IWD · iShares Trust | 0,34% | 1 404 243 SH | 11 września 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,34% | 381 505 SH | 19 sierpnia 2026 | Dziennie |
| SUSA · iShares Trust | 0,29% | 58 103 SH | 11 września 2026 | Dziennie |
| OEF · iShares Trust | 0,27% | 266 715 SH | 11 września 2026 | Dziennie |
| VFVA · VANGUARD WELLINGTON FUND | 0,25% | 11 236 SH | 19 sierpnia 2026 | Dziennie |
| DFLV · Dimensional ETF Trust | 0,24% | 84 826 NS | 31 lipca 2026 | N-PORT |
| DGRO · iShares Trust | 0,24% | 521 760 SH | 11 września 2026 | Dziennie |
| USCL · iShares Trust | 0,24% | 33 717 SH | 11 września 2026 | Dziennie |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,24% | 17 762 SH | 1 października 2026 | Dziennie |
| TOPC · iShares Trust | 0,23% | 381 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,23% | 102 555 SH | 1 października 2026 | Dziennie |
| MGC · VANGUARD WORLD FUND | 0,23% | 127 343 SH | 19 sierpnia 2026 | Dziennie |
| ACVF · ETF Opportunities Trust | 0,23% | 1 783 NS | 31 lipca 2026 | N-PORT |
| IWL · iShares Trust | 0,22% | 24 594 SH | 11 września 2026 | Dziennie |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,22% | 306 000 | 1 października 2026 | Dziennie |
| RSP · Invesco Exchange-Traded Fund Trust | 0,22% | 955 827 SH | 1 października 2026 | Dziennie |
| SIZE · iShares Trust | 0,22% | 4 614 SH | 11 września 2026 | Dziennie |
| XVV · iShares Trust | 0,22% | 7 252 SH | 11 września 2026 | Dziennie |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,21% | 109 973 SH | 1 października 2026 | Dziennie |
| PBP · Invesco Exchange-Traded Fund Trust | 0,21% | 3 722 SH | 1 października 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,21% | 142 869 SH | 19 sierpnia 2026 | Dziennie |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 4 805 NS | 31 lipca 2026 | N-PORT |
| ILCB · iShares Trust | 0,20% | 12 530 SH | 11 września 2026 | Dziennie |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 88 851 NS | 31 lipca 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,19% | 10 899 NS | 31 lipca 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,19% | 18 450 SH | 11 września 2026 | Dziennie |
| IVV · iShares Trust | 0,19% | 7 939 826 SH | 11 września 2026 | Dziennie |
| VOXP · Advisors Series Trust | 0,19% | 57 NS | 31 lipca 2026 | N-PORT |
| XCLR · Global X Funds | 0,19% | 35 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,19% | 31 952 NS | 31 lipca 2026 | N-PORT |
| XRMI · Global X Funds | 0,19% | 489 NS | 31 lipca 2026 | N-PORT |
| XYLD · Global X Funds | 0,19% | 31 674 NS | 31 lipca 2026 | N-PORT |
| XTR · Global X Funds | 0,19% | 47 NS | 31 lipca 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,19% | 16 363 510 SH | 19 sierpnia 2026 | Dziennie |
| VV · VANGUARD INDEX FUNDS | 0,19% | 743 939 SH | 19 sierpnia 2026 | Dziennie |
| TOV · EA Series Trust | 0,19% | 2 581 NS | 31 lipca 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,19% | 53 257 NS | 31 lipca 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,19% | 2 836 NS | 31 lipca 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,19% | 22 752 NS | 31 lipca 2026 | N-PORT |
| XYLG · Global X Funds | 0,19% | 616 NS | 31 lipca 2026 | N-PORT |
| IWB · iShares Trust | 0,18% | 437 462 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,18% | 27 014 SH | 11 września 2026 | Dziennie |
| PEVC · Pacer Funds Trust | 0,18% | 22 NS | 31 lipca 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,18% | 493 SH | 1 października 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,18% | 189 347 NS | 31 lipca 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,18% | 2 377 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,17% | 174 302 SH | 11 września 2026 | Dziennie |
| QDPL · Pacer Funds Trust | 0,17% | 15 178 NS | 31 lipca 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,17% | 5 511 000 | 30 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,17% | 820 097 SH | 11 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,17% | 20 226 391 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,17% | 104 620 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,17% | 53 219 SH | 19 sierpnia 2026 | Dziennie |
| ESGU · iShares Trust | 0,17% | 151 590 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,16% | 18 486 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,15% | 1 797 SH | 11 września 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,15% | 4 381 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,15% | 17 583 NS | 31 lipca 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,15% | 31 921 SH | 1 października 2026 | Dziennie |
| CRBN · iShares Trust | 0,15% | 8 649 SH | 11 września 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,14% | 49 245 NS | 31 lipca 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,14% | 61 098 SH | 1 października 2026 | Dziennie |
| URTH · iShares, Inc. | 0,14% | 56 946 SH | 11 września 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,13% | 83 138 NS | 31 lipca 2026 | N-PORT |
| ACWI · iShares Trust | 0,12% | 201 808 SH | 11 września 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,12% | 20 495 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,11% | 3 763 SH | 1 października 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,10% | 523 769 SH | 19 sierpnia 2026 | Dziennie |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,09% | 7 398 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,08% | 206 412 NS | 31 lipca 2026 | N-PORT |
| FBCG · FIDELITY COVINGTON TRUST | 0,07% | 25 158 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,05% | 1 457 NS | 31 lipca 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,05% | 104 339 SH | 11 września 2026 | Dziennie |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCEB · VANGUARD WORLD FUND | · | · | 30 lipca 2026 | Dziennie |
DHR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
22 analityków · 2026-10-02Średnia cel $234.73 +9,7%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | · |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | · |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | · |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | · |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.